质子治疗中心在线广告声明与指南推荐的一致性评估
该研究评估了全球46个质子治疗中心英文网站的直接面向消费者的广告内容与声明。作者建议质子治疗提供者应使在线信息与公认指南和共识保持一致。
核心结论
- 质子治疗中心网站信息常与国际共识指南推荐不一致。
- 在线营销信息可能显著影响患者决策,提供者应使信息与公认指南和共识保持一致。
研究设计与样本
- 通过粒子治疗协作组网站识别运营中的质子治疗中心英文网站。
- 由两名研究者独立提取网站内容数据,并参考八项国际指南确定基于指南的质子放疗适应症。
- 采用单因素和多因素逻辑回归模型分析网站声称质子放疗提供更佳疾病控制或治愈率的特征。
临床怎么用
- 放射治疗科医生应了解质子治疗中心网站信息可能与指南不一致,需引导患者基于循证指南决策。
- 质子治疗提供者应使在线营销信息与公认指南和共识保持一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer patients frequently search the Internet for treatment options, and hospital websites are seen as reliable sources of knowledge. Guidelines support the use of proton radiotherapy in specific disease sites or on clinical trials. This study aims to evaluate direct-to-consumer advertising content and claims made by proton therapy centre (PTC) websites worldwide. METHODS: Operational PTC websites in English were identified through the Particle Therapy Co-Operative Group website. Data abstraction of website content was performed independently by two investigators. Eight international guidelines were consulted to determine guideline-based indications for proton radiotherapy. Univariate and multivariate logistic regression models were used to determine the characteristics of PTC websites that indicated proton radiotherapy offered greater disease control or cure rates. RESULTS: Forty-eight PTCs with 46 English websites were identified. 60·9% of PTC websites claimed proton therapy provided improved disease control or cure. U.S. websites listed more indications than international websites (15·5 ± 5·4 vs. 10·4 ± 5·8, p = 0·004). The most common disease sites advertised were prostate (87·0%), head and neck (87·0%) and pediatrics (82·6%), all of which were indicated in least one international guideline. Several disease sites advertised were not present in any consensus guidelines, including pancreatobiliary (52·2%), breast (50·0%), and esophageal (43·5%) cancers. Multivariate analysis found increasing number of disease sites and claiming their centre was a local or regional leader in proton radiotherapy was associated with indicating proton radiotherapy offers greater disease control or cure. CONCLUSIONS: Information from PTC websites often differs from recommendations found in international consensus guidelines. As online marketing information may have significant influence on patient decision-making, alignment of such information with accepted guidelines and consensus opinion should be adopted by PTC providers.
引用
- Corkum MT, Liu W, Palma DA, et al. Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based? Radiat Oncol. 2018. PMID: 29544511. doi:10.1186/s13014-018-0988-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。